• FirefoxInstall the new Firefox »
  •  Dow Down 0.45% Nasdaq Down 0.49%

    Janus Global Life Sciences D (JNGLX)

    58.29 Down 0.41(0.70%) Feb 27
    Prev Close:58.70
    YTD Return*:4.35%
    Net Assets*:3.63B
    Yield*:N/A

    * As of 31-Jan-15

    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    • No Headlines available for JNGLX at this time.

    Top Holdings

    Symbol% AssetsYTD Return %
    JNJ2.98-3.58
    BIIB2.7214.89
    AMGN2.56-4.26
    VRX.TO2.3013.19
    CELG2.286.00

    Fund Basics

    Morningstar Overall Rating:
    Total Assets:3.63B
    Category:Health
    Annual Report Expense Ratio (net):0.84%

    Performance & Risk

    YTD Return:4.35%
    5y Avg Return:25.99%
    Rank in Category (ytd):16
    % Rank in Category (ytd):12.5%
    Beta (3y):0.64
    Morningstar Risk Rating:3

    Fund Summary

    The investment seeks long-term growth of capital. The fund pursues its investment objective by investing, under normal circumstances, at least 80% of its net assets in securities of companies that the portfolio manager believes have a life science orientation. In the fund's pursuit of companies with a life science orientation, the fund has a fundamental policy to normally invest at least 25% of its total assets in securities of companies that are categorized in the "life sciences" sector. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback